Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK)
Abroad (travel likely)Recruiting
Conditions
Breast Cancer · Lung Cancer · Melanoma · Gynecologic Cancer · Genitourinary Cancer · Pancreatobiliary Cancer · Gastrointestinal Cancer · Head and Neck Cancer · Rare Cancer · Unknown Primary Tumors
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Princess Margaret Hospital, Toronto, Ontario, Canada
Contact: Principal Investigator (Lillian Siu, MD)Contact: Principal Investigator (Scott Bratman, MD)
Study leads
Lillian Siu, MD
Principal Investigator
Princess Margaret Cancer Centre
Scott Bratman, MD
Principal Investigator
Princess Margaret Cancer Centre